Dr. Andy Hill was asked to evaluate several studies that showed Ivermectin as an effective treatment for COVID-19 for the World Health Organization (WHO) in late 2020. At the same time, U.K. doctor Dr. Tess Lawrie, and two U.S. doctors, Pierre Kory, M.D. and Paul Marik, M.D., were sharing with Hill data and hopeful anecdotal evidence substantiating the effectiveness of Ivermectin as a treatment for COVID-19. Hill had agreed to collaborate, but he instead preempted any further dialogue. “Before [they] could collaborate,” says Lawrie, “Hill published his paper as a preprint” in early 2021. His paper was later retracted.
Hill’s findings on Ivermectin were primarily positive. However, despite seeing evidence of Ivermectin’s effectiveness, Hill concluded in his paper that Ivermectin was still not ready for prime time. Shortly after that, millions began to receive the mRNA vaccines even though there was plenty of evidence showing Ivermectin was saving lives.
Dr. Hill’s preprint reflected a systematic study of trial data on the efficacy of Ivermectin in treating COVID-19. Despite his having written in his review that “Ivermectin was associated with reduced inflammatory markers…faster viral clearance by PCR, significantly shortened duration of hospitalization, and favorable clinical recovery,” his conclusion perplexingly stated otherwise.
Click here to read the full article